• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • ‘Special Ops 2’ trailer: Kay Kay Menon returns as RAW agent Himmat Singh
    • Cook, clean, pray: An essay on what it means to be an ordinary working-class woman in Srinagar
    • The key question missing in India’s debate over ‘taxi mafia’ and ride-hailing apps
    • Rush Hour: Modi tells Trump ‘India won’t accept mediation’, Delhi and Ottawa to repost envoys & more
    • Goa’s ‘taxi mafia’: What tourists need to know
    • How the lives of a married couple from Ghaziabad were upended by BJP leader’s ‘love jihad’ claims
    • Management consultant Arun Maira studies the socioeconomic evolution of India’s ‘tryst with destiny’
    • Assam: 7 arrested after alleged cattle skull found near prayer hall, says Himanta Sarma
    • How reliable are the rankings of India's top IITs and IIMs?
    • Photo essay: Nine ways of seeing deserts as landscapes of richness – not symbols of failure
    • Caught in Iran crossfire, Kashmiri students wait for a passage home
    • Why RSS outfit members are at centre of a Rs 14-crore scam at ICHR
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

compulsory licencing

  • Bad news for patients as the government weakens the drug price regulator and meddles with price caps

    Bad news for patients as the government weakens the drug price regulator and meddles with price caps

    S Srinivasan
    · Mar 08, 2019 · 02:30 pm
  • Switzerland wants stricter intellectual property rules in India that could harm generic drug makers

    Switzerland wants stricter intellectual property rules in India that could harm generic drug makers

    Jyotsna Singh
    · Mar 23, 2017 · 07:03 pm